Shares of Palantir Technologies Inc. (NASDAQ:PLTR) were mostly flat over the past five trading sessions, falling by 0.10%.

image for news Palantir Technologies (NASDAQ: PLTR) Price Prediction and Forecast 2025-2030 for May 26

Best Natural and Organic Food Stocks to Keep an Eye On in 2025 — Positive

BYND  GIS  SFM  UNFI   Zacks Investment Research — May 26, 2025

Sprouts Farmers, United Natural, Beyond Meat and General Mills are betting big on organic, clean-label foods and redefining what's healthy on store shelves.

image for news Best Natural and Organic Food Stocks to Keep an Eye On in 2025

Dycom Jumps 39% in 3 Months: Should You Buy, Sell or Hold the Stock? — Positive

DY   Zacks Investment Research — May 26, 2025

DY gains from fiber-to-the-home programs and hyperscaler projects, offsetting macro and tariff headwinds with strong long-term growth visibility.

image for news Dycom Jumps 39% in 3 Months: Should You Buy, Sell or Hold the Stock?

Should You Buy MRK Stock At $80? — Negative

MRK   Forbes — May 26, 2025

Merck (NYSE:MRK) stock has experienced a significant 22% decline this year, sharply underperforming the broader S&P 500 index, which is down only 1%. This downturn can be attributed to several factors: a lowered guidance for 2025 and growing concerns about the long-term growth prospects of its blockbuster drugs, Keytruda and Gardasil.

image for news Should You Buy MRK Stock At $80?

NEW YORK CITY, NY / ACCESS Newswire / May 26, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc. (NASDAQ:TMCI) between May 8, 2023 and May 7, 2024, both dates inclusive (the "Class Period"), of the important June 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Treace Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

image for news ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TMCI

NEW YORK CITY, NY / ACCESS Newswire / May 26, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE:WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the important July 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased West common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

image for news ROSEN, NATIONAL TRIAL LAWYERS, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WST

NEW YORK CITY, NY / ACCESS Newswire / May 25, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of DoubleVerify Holdings, Inc. (NYSE: DV) between November 10, 2023 and February 27, 2025, both dates inclusive (the "Class Period"). If you wish to serve as lead plaintiff, you must move the Court no later than July 21, 2025.

image for news ROSEN, TRUSTED INVESTOR COUNSEL, Encourages DoubleVerify Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DV

NEW YORK CITY, NY / ACCESS Newswire / May 26, 2025 / WHY: New York, N.Y., May 26, 2025.

image for news ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Open Lending Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - LPRO

Gorilla Pops 14.6% on Buyback Completion: Should You Buy GRRR Now? — Positive

GRRR   Zacks Investment Research — May 26, 2025

GRRR rallies after completing $5.4M in buybacks and lifting insider ownership to 20%, with 2025 growth and margins tracking higher.

image for news Gorilla Pops 14.6% on Buyback Completion: Should You Buy GRRR Now?

Wix Acquires Hour One to Boost Generative AI and Drive Innovation — Positive

WIX   Zacks Investment Research — May 26, 2025

WIX acquires Hour One to scale AI media creation, boost immersive web design and cut reliance on third parties for front-end innovation.

image for news Wix Acquires Hour One to Boost Generative AI and Drive Innovation

Cautious Optimism in Gap's Pre-Q1 Earnings: Buy or Hold for Now? — Positive

GAP   Zacks Investment Research — May 26, 2025

GAP expects modest Q1 growth, margin expansions and brand momentum, with cost controls helping offset macro and tariff headwinds in the upcoming report.

image for news Cautious Optimism in Gap's Pre-Q1 Earnings: Buy or Hold for Now?

CrowdStrike: Don't Chase, As Q1 Results Are Unlikely To Be Stellar — Positive

CRWD   Seeking Alpha — May 26, 2025

CrowdStrike has outperformed both the market and cybersecurity peers quite handsomely this year, with the sustainability of this alpha likely to be dictated by Q1 earnings on the 3rd of June. The pace of sales growth is expected to dip even further, but the decline in new ARR may not be as bad as what was seen in H2-25. CRWD is due to face pressure on the operational margin front, as it ramps up investments and incurs one-off costs.

image for news CrowdStrike: Don't Chase, As Q1 Results Are Unlikely To Be Stellar

MercadoLibre Rises 47% YTD: Should You Buy, Sell or Hold the Stock? — Neutral

MELI   Zacks Investment Research — May 26, 2025

MELI surges 47% YTD on strong earnings and user growth, but credit risks and fierce competition prompt a cautious hold recommendation.

image for news MercadoLibre Rises 47% YTD: Should You Buy, Sell or Hold the Stock?

The New York Times Company Leverages Digital Subscriptions for Growth — Positive

NYT   Zacks Investment Research — May 26, 2025

NYT adds 11.06M digital-only subscribers in Q1, lifting digital revenues by 14.4% and boosting ARPU to $9.54, as it navigates away from declining print.

image for news The New York Times Company Leverages Digital Subscriptions for Growth

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Backblaze, Inc. (NASDAQ:BLZE) resulting from allegations that Backblaze may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Backblaze securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

image for news TOP RANKED ROSEN LAW FIRM Encourages Backblaze, Inc. Investors to Inquire About Securities Class Action Investigation - BLZE

NEW YORK, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your BigBear.ai Holdings, Inc. (NYSE:BBAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bigbear-ai-holdings-inc-lawsuit-submission-form?prid=150244&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq.

image for news Investors in BigBear.ai Holdings, Inc. (BBAI): Protect Your Rights - Contact Levi & Korsinsky Before June 10, 2025

NEW YORK, NY / ACCESS Newswire / May 26, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bitfarms Ltd. (NASDAQ:BITF) between March 21, 2023 and December 9, 2024, both dates inclusive (the "Class Period"), of the important July 8, 2025 lead plaintiff.

image for news ROSEN, A LEADING LAW FIRM, Encourages Bitfarms Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BITF

When It Rains Gold, Put Out The Bucket: 2 Wonderful Income Bargains — Positive

BMY  REXR   Seeking Alpha — May 26, 2025

Focus on high-quality, dividend-paying stocks with temporary setbacks, offering both value and income for patient investors. Bristol-Myers Squibb is deeply undervalued, carries a 5.3% yield, strong profitability, and a promising neurodegenerative drug pipeline. Rexford Industrial Realty offers a 5% yield, benefits from supply-constrained Southern California industrial markets, and trades far below historical valuation.

image for news When It Rains Gold, Put Out The Bucket: 2 Wonderful Income Bargains

NEW YORK, NY / ACCESS Newswire / May 26, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Canopy Growth Corporation (NASDAQ:CGC) between May 30, 2024 and February 6, 2025, both dates inclusive (the "Class Period"), of the important June 3, 2025 lead plaintiff deadline. SO WHAT: If you purchased Canopy Growth securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

image for news CGC DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Canopy Growth Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action - CGC

Abercrombie Shows Uncertainty Before Q1 Earnings: Buy Now or Step Back? — Negative

ANF   Zacks Investment Research — May 26, 2025

ANF eyes modest Q1 revenue growth, but earnings dip, cost pressures and tariff risks cloud near-term outlook ahead of the May 28 earnings release.

image for news Abercrombie Shows Uncertainty Before Q1 Earnings: Buy Now or Step Back?